135 related articles for article (PubMed ID: 6124136)
1. Fluphenazine decanoate and tardive dyskinesia.
Schiff AA
Am J Psychiatry; 1982 Jul; 139(7):969-70. PubMed ID: 6124136
[No Abstract] [Full Text] [Related]
2. [Tardive dystonia--a case report on therapy and metaphylaxis].
Genz A
Psychiatr Neurol Med Psychol (Leipz); 1988 May; 40(5):264-8. PubMed ID: 2905065
[TBL] [Abstract][Full Text] [Related]
3. Fluphenazine decanoate and tardive dyskinesia: a possible association.
Csernansky JG; Grabowski K; Cervantes J; Kaplan J; Yesavage JA
Am J Psychiatry; 1981 Oct; 138(10):1362-5. PubMed ID: 7294195
[TBL] [Abstract][Full Text] [Related]
4. [Tardive dystonia: a rare side effect after long-term neuroleptic treatment].
Bartels M; Riffel B; Stöhr M
Nervenarzt; 1982 Nov; 53(11):674-6. PubMed ID: 6129578
[No Abstract] [Full Text] [Related]
5. Tardive dyskinesia, fluphenazine decanoate, and haloperidol.
Waddington JL
Am J Psychiatry; 1982 May; 139(5):703-4. PubMed ID: 7072867
[No Abstract] [Full Text] [Related]
6. Induction of tardive dyskinesia in Cebus apella and Macaca speciosa monkeys: a review.
Domino EF
Psychopharmacology Suppl; 1985; 2():217-23. PubMed ID: 2860660
[TBL] [Abstract][Full Text] [Related]
7. Clozapine and tardive dyskinesia.
Miller DD
Am J Psychiatry; 2003 Mar; 160(3):588. PubMed ID: 12611849
[No Abstract] [Full Text] [Related]
8. Abnormal involuntary movements in patients on long-acting neuroleptics.
Oyewumi LK; Lapierre YD; Gray R; Batth S; Gelfand R
Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(4-6):719-23. PubMed ID: 6141614
[TBL] [Abstract][Full Text] [Related]
9. The opiate antagonist naloxone suppresses a rodent model of tardive dyskinesia.
Stoessl AJ; Polanski E; Frydryszak H
Mov Disord; 1993 Oct; 8(4):445-52. PubMed ID: 7901759
[TBL] [Abstract][Full Text] [Related]
10. Tardive dyskinesia and current dose of neuroleptic drugs.
Kolakowska T; Williams AO; Ardern M
Arch Gen Psychiatry; 1985 Sep; 42(9):925. PubMed ID: 2864034
[No Abstract] [Full Text] [Related]
11. Movement disorders in patients treated with long-acting injectable antipsychotic drugs.
Bransgrove LL; Kelly MW
Am J Hosp Pharm; 1994 Apr; 51(7):895-9. PubMed ID: 7912473
[TBL] [Abstract][Full Text] [Related]
12. Drug history and tardive dyskinesia.
Smith RC; Strizich M; Klass D
Am J Psychiatry; 1978 Nov; 135(11):1402-3. PubMed ID: 30289
[No Abstract] [Full Text] [Related]
13. Tardive dyskinesia in schizophrenics under 60 years of age.
Kolakowska T; Williams AO; Ardern M; Reveley MA
Biol Psychiatry; 1986 Feb; 21(2):161-9. PubMed ID: 2868762
[TBL] [Abstract][Full Text] [Related]
14. Fluphenazine decanoate. Its steady-state pharmacologic profile and relationship to tardive dyskinesia.
Glazer WM
Schizophr Res; 1988; 1(6):425-9. PubMed ID: 3154530
[TBL] [Abstract][Full Text] [Related]
15. A prospective study of tardive dyskinesia development: preliminary results.
Kane JM; Woerner M; Weinhold P; Wegner J; Kinon B
J Clin Psychopharmacol; 1982 Oct; 2(5):345-9. PubMed ID: 6127353
[TBL] [Abstract][Full Text] [Related]
16. Tardive dyskinesia and current dose of neuroleptic drugs.
Kolakowska T; Williams AO; Ardern M
Arch Gen Psychiatry; 1986 Jun; 43(6):614. PubMed ID: 2871820
[No Abstract] [Full Text] [Related]
17. Tardive dyskinesia: are first signs reversible?
Quitkin F; Rifkin A; Gochfeld L; Klein DF
Am J Psychiatry; 1977 Jan; 134(1):84-7. PubMed ID: 12666
[TBL] [Abstract][Full Text] [Related]
18. Tardive dyskinesia complicated by hyperthyroidism.
Munetz MR; Ginchereau EH; Toenniessen LM
Psychosomatics; 1987 Oct; 28(10):553-5. PubMed ID: 3432519
[No Abstract] [Full Text] [Related]
19. Fluphenazine and tardive dyskinesia.
Perényi A; Arató M
Arch Gen Psychiatry; 1984 Jul; 41(7):727. PubMed ID: 6732436
[No Abstract] [Full Text] [Related]
20. Drug variables in the etiology of tardive dyskinesia application of discriminant function analysis.
Gardos G; Cole JO; La Brie RA
Prog Neuropsychopharmacol; 1977; 1(1-2):147-54. PubMed ID: 31640
[No Abstract] [Full Text] [Related]
[Next] [New Search]
